Great Point Partners LLC
- SEC CIK
- 0001281446
- Latest filing
- Aug 14, 2026
VRDN holding history
Viridian Therapeutics, Inc. in every 13F filed by Great Point Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −750,000−100.0% | Sold out | Holders |
| Q1 2025 | 750,000 | $10.1M | 5.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 750,000 | $14.4M | 6.8% | 00.0% | Unchanged | Holders |
| Q3 2024 | 750,000 | $17.1M | 5.1% | +250,000+50.0% | Added | Holders |
| Q2 2024 | 500,000 | $6.50M | 1.2% | −835,000−62.5% | Reduced | Holders |
| Q1 2024 | 1,335,000 | $23.4M | 3.6% | +1,335,000 | New | Holders |